Key clinical point: Adults with asthma–COPD overlap syndrome (ACOS) who used statins had a lower risk of anxiety and depression than nonstatin users.
Major finding: Statin users had significantly lower risks of anxiety (adjusted hazard ratio, 0.34) and depression (aHR, 0.36), compared with nonstatin users.
Study details: The data come from a retrospective cohort study of 1,252 statin users and 7,887 nonstatin users in Taiwan.
Disclosures: The study was supported by grants from a variety of organizations in Taiwan, China, and Japan. Dr. Jun-Jun Yeh and associates had no financial conflicts to disclose.
Yeh J et al. J Affect Disord. 2019 Jun 15; 253:277-84.
This Week's Must Reads
Acute Illness and Cannabis Use in Adults, Ann Intern Med; ePub 2019 Mar 26; Monte, et al
Must Reads in Asthma
Antibiotic Therapy in Patients with Asthma, JAMA Intern Med; ePub 2019 Jan 28; Stefan, et al
Asthma Toolkit Improves Measures of Asthma Care, J Am Board Fam Med; 2019 Jan; Colborn, et al
Fractional Exhaled Nitric Oxide Testing in Asthma, Mayo Clin Proc; ePub 2017 Dec 20; Wang, et al
Pharmacologic Tx of Seasonal Allergic Rhinitis, Ann Intern Med; ePub 2017 Nov 28; Wallace, et al